Utility of Multiparametric Magnetic Resonance Imaging Suspicion Levels for Detecting Prostate Cancer

The Journal of Urology - Tập 190 - Trang 1721-1727 - 2013
Soroush Rais-Bahrami1, M. Minhaj Siddiqui1, Baris Turkbey2, Lambros Stamatakis1, Jennifer Logan1, Anthony N. Hoang1, Annerleim Walton-Diaz1, Srinivas Vourganti1, Hong Truong1, Jochen Kruecker3,4, Maria J. Merino5, Bradford J. Wood3, Peter L. Choyke2, Peter A. Pinto1,3
1Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
2Molecular Imaging Program, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
3Center for Interventional Oncology, National Cancer Institute & Clinical Center, National Institutes of Health, Bethesda, Maryland
4Philips Research North America, Briarcliff Manor, New York
5Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland

Tài liệu tham khảo

Siegel, 2012, Cancer statistics, 2012, CA Cancer J Clin, 62, 10, 10.3322/caac.20138 Egevad, 2002, Prognostic value of the Gleason score in prostate cancer, BJU Int, 89, 538, 10.1046/j.1464-410X.2002.02669.x Belas, 2012, Low accuracy of routine ultrasound-guided systematic 12-core biopsies in prostate tumor mapping, Can J Urol, 19, 6366 Kvale, 2009, Concordance between Gleason scores of needle biopsies and radical prostatectomy specimens: a population-based study, BJU Int, 103, 1647, 10.1111/j.1464-410X.2008.08255.x Conti, 2009, Pathological outcomes of candidates for active surveillance of prostate cancer, J Urol, 181, 1628, 10.1016/j.juro.2008.11.107 Pinto, 2011, Magnetic resonance imaging/ultrasound fusion guided prostate biopsy improves cancer detection following transrectal ultrasound biopsy and correlates with multiparametric magnetic resonance imaging, J Urol, 186, 1281, 10.1016/j.juro.2011.05.078 Turkbey, 2011, Multiparametric 3T prostate magnetic resonance imaging to detect cancer: histopathological correlation using prostatectomy specimens processed in customized magnetic resonance imaging based molds, J Urol, 186, 1818, 10.1016/j.juro.2011.07.013 Sonn, 2013, Targeted biopsy in the detection of prostate cancer using an office based magnetic resonance ultrasound fusion device, J Urol, 189, 86, 10.1016/j.juro.2012.08.095 Hadaschik, 2011, A novel stereotactic prostate biopsy system integrating pre-interventional magnetic resonance imaging and live ultrasound fusion, J Urol, 186, 2214, 10.1016/j.juro.2011.07.102 Vourganti, 2012, Multiparametric magnetic resonance imaging and ultrasound fusion biopsy detect prostate cancer in patients with prior negative transrectal ultrasound biopsies, J Urol, 188, 2152, 10.1016/j.juro.2012.08.025 Turkbey, 2010, Prostate cancer: value of multiparametric MR imaging at 3 T for detection–histopathologic correlation, Radiology, 255, 89, 10.1148/radiol.09090475 Turkbey, 2013, Prostate cancer: can multiparametric MR imaging help identify patients who are candidates for active surveillance?, Radiology, 268, 144, 10.1148/radiol.13121325 Hernandez, 2004, Prostate-specific antigen: a review of the validation of the most commonly used cancer biomarker, Cancer, 101, 894, 10.1002/cncr.20480 Derweesh, 2004, Continuing trends in pathological stage migration in radical prostatectomy specimens, Urol Oncol, 22, 300, 10.1016/j.urolonc.2003.11.011 Etzioni, 2008, Quantifying the role of PSA screening in the US prostate cancer mortality decline, Cancer Causes Control, 19, 175, 10.1007/s10552-007-9083-8 U.S. Preventive Services Task Force: Screening for Prostate Cancer: U.S. Preventive Services Task Force recommendation statement: draft: summary of recommendation and evidence. October 7, 2011. Moyer, 2012, Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement, Ann Intern Med, 157, 120, 10.7326/0003-4819-157-2-201207170-00459 Epstein, 1994, Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer, JAMA, 271, 368, 10.1001/jama.1994.03510290050036 Iremashvili, 2012, Pathologic prostate cancer characteristics in patients eligible for active surveillance: a head-to-head comparison of contemporary protocols, Eur Urol, 62, 462, 10.1016/j.eururo.2012.03.011 Rastinehad, 2011, D’Amico risk stratification correlates with degree of suspicion of prostate cancer on multiparametric magnetic resonance imaging, J Urol, 185, 815, 10.1016/j.juro.2010.10.076 Vargas, 2012, Magnetic resonance imaging for predicting prostate biopsy findings in patients considered for active surveillance of clinically low risk prostate cancer, J Urol, 188, 1732, 10.1016/j.juro.2012.07.024 Zhang, 2009, Clinical stage T1c prostate cancer: evaluation with endorectal MR imaging and MR spectroscopic imaging, Radiology, 253, 425, 10.1148/radiol.2532081390 Nix, 2012, Very distal apical prostate tumours: identification on multiparametric MRI at 3 Tesla, BJU Int, 110, E694, 10.1111/j.1464-410X.2012.11503.x Ouzzane, 2011, Combined multiparametric MRI and targeted biopsies improve anterior prostate cancer detection, staging, and grading, Urology, 78, 1356, 10.1016/j.urology.2011.06.022 Stamey, 1993, Localized prostate cancer: relationship of tumor volume to clinical significance for treatment of prostate cancer, Cancer, 71, 933, 10.1002/1097-0142(19930201)71:3+<933::AID-CNCR2820711408>3.0.CO;2-L Turkbey, 2012, Correlation of magnetic resonance imaging tumor volume with histopathology, J Urol, 188, 1157, 10.1016/j.juro.2012.06.011